Health-related quality of life as an endpoint in oncology phase I trials: a systematic review

BACKGROUND: Phase I trials aim to identify the recommended dose for further development. Health-related quality of life (HRQoL) could be a complement to the usual National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) scale to detect adverse events and define the doses....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Fiteni, Frédéric, Ray, Isabelle Le, Ousmen, Ahmad, Isambert, Nicolas, Anota, Amélie, Bonnetain, Franck
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6469065/
https://ncbi.nlm.nih.gov/pubmed/30991990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5579-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky